GEORGE LEVY, M.D.; W. R. MEADOWS, M.D.; ROLF M. GUNNAR, M.D.
This content is PDF only. Please click on the PDF icon to access.
Since the introduction of neostigmine1, 2 as a test for myasthenia gravis, there have been 16 cases3 of myasthenia gravis associated with Graves' disease reported in the literature. In this same period there have been reported a few cases of Graves' disease with muscular weakness which responded to neostigmine but were considered to be thyrotoxic myopathy. However, Brain's classification of muscular disorders associated with Graves' disease4 lends validity to the separation of myasthenia gravis from other types of muscular weakness occurring in association with Graves' disease on the basis of the response to neostigmine.
In this paper we present five
LEVY G, MEADOWS WR, GUNNAR RM. THE ASSOCIATION OF GRAVES' DISEASE WITH MYASTHENIA GRAVIS, WITH A REPORT OF FIVE CASES1. Ann Intern Med. 1951;35:134–147. doi: 10.7326/0003-4819-35-1-134
Download citation file:
Published: Ann Intern Med. 1951;35(1):134-147.
Endocrine and Metabolism, Neurology, Thyroid Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use